Clinical criteria include common and relevant signs and symptoms of the disease which either individually or in combination constitutes a clear or indicative clinical picture of the disease. They give the general outline of the disease and do not necessarily indicate all the features needed for individual clinical diagnosis.
Laboratory criteria are a list of laboratory methods that are used to confirm a case. Usually only one of the listed tests will be enough to confirm the case. If a combination of methods is needed to meet the laboratory confirmation, this is specified. The type of specimen to be collected for the laboratory tests is only specified when only certain specimen types are considered relevant for the confirmation of a diagnosis. Laboratory criteria for a probable case are included for some agreed exceptional cases. Those laboratory criteria consist of a list of laboratory methods which can be used to support the diagnosis of a case but which are not confirmatory.
Epidemiological criteria are deemed to have been met when an epidemiological link can be established.
Epidemiological link, during the incubation period, means one of the following six:
—Human to human transmissionthe fact that a person has had contact with a laboratory confirmed human case in such a way as to have had the opportunity to acquire the infection;
—Animal to human transmissionthe fact that a person has had contact with an animal with a laboratory confirmed infection/colonization in such a way as to have had the opportunity to acquire the infection;
—Exposure to a common sourcethe fact that a person has been exposed to the same common source or vehicle of infection, as a confirmed human case;
—Exposure to contaminated food/drinking waterthe fact that a person has consumed food or drinking water with a laboratory confirmed contamination or has consumed potentially contaminated products from an animal with a laboratory confirmed infection/colonization;
—Environmental exposurethe fact that a person has bathed in water or has had contact with a contaminated environmental source that has been laboratory confirmed;
—Laboratory exposurethe fact that a person has worked in a laboratory where there is a potential for exposure.
A person may be considered epidemiologically linked to a confirmed case if at least one case in the chain of transmission is laboratory confirmed. In case of an outbreak of faeco-oral or airborne transmitted infections, the chain of transmission does not necessarily need to be established to consider a case epidemiologically linked.
Transmission may occur by one or more of the following routes:
Airborne: by projection of aerosol from an infected person onto the mucous membranes while coughing, spitting, singing or talking, or when microbial aerosols dispersed into the atmosphere are inhaled by others;
Contact: direct contact with an infected person (faecal-oral, respiratory droplets, skin or sexual exposure) or animal (for example, biting, touching) or indirect contact to infected materials or objects (infected fomites, body fluids, blood);
Vertical: from mother to child, often in utero, or as a result of the incidental exchange of body fluids usually during the perinatal period;
Vector transmission: transmission by infected mosquitoes, ticks, mites, flies and other insects which transmit disease to humans through their bites;
Food or water: consumption of potentially contaminated food or drinking water.
Cases are classified as ‘possible’, ‘probable’ and ‘confirmed’. The incubation periods for diseases are given in the additional information to facilitate the assessment of the epidemiological link.
A possible case means a case classified as possible for reporting purposes. It is usually a case meeting the clinical criteria as described in the case definition without epidemiological or laboratory evidence of the disease in question. The definition of a case as possible has high sensitivity and low specificity. It allows for detection of most cases but some false positives cases will be included into this category.
A probable case means a case classified as probable for reporting purposes. It is usually a case with clinical criteria and an epidemiological link as described in the case definition. Laboratory tests for probable cases are specified only for some diseases.
A confirmed case means a case classified as confirmed for reporting purposes. Confirmed cases are laboratory confirmed and may or may not fulfil the clinical criteria as described in the case definition. The definition of a case as confirmed is highly specific and less sensitive; therefore most of the collected cases will be true cases although some will be missed.
The clinical criteria of some diseases do not allude to the fact that many acute cases are asymptomatic (for example, hepatitis A, B and C, campylobacteriosis, salmonellosis) although these cases may still be important from a public health perspective on national level.
Confirmed cases fall in one of the three subcategories listed below. They will be assigned to one of those subcategories during the analysis of data using the variables collected within the context of the case information.
The case meets the laboratory criteria for case confirmation and the clinical criteria included in the case definition.
The case meets the laboratory criteria for case confirmation but there is no information available regarding the clinical criteria (for example,only laboratory report).
The case meets the laboratory criteria for case confirmation but doesn't meet the clinical criteria in the case definition or is asymptomatic.
Note: For some of the conditions under surveillance the structure of the case definitions does not follow the typical structure of the case definition such as in the cases of Creutzfeldt-Jakob disease (CJD), healthcare associated infections and antimicrobial resistance.
1.AFPacute flaccid paralysis
2.AIDSacquired immune deficiency syndrome
3.AMRantimicrobial resistance
4.Anti-HBchepatitis B core antibody
5.anti-HCVhepatitis C virus specific antibody
6.ARIacute respiratory infection
7.BALbroncho-alveolar lavage
8.BCGBacille de Calmette et Guérin
9.BJbone and joint infection
10.BJ-BONEosteomyelitis
11.BJ-DISCdisc space infection
12.BJ-JNTjoint or bursa infection
13.BoNTbotulinum neurotoxin
14.BSIbloodstream infection
15.C-CVCcatheter-related — central venous catheter
16.CDADClostridium difficile associated diarrhoea
17.CFUcolony-forming unit
18.CJDCreutzfeldt-Jakob disease
19.CMVcytomegalovirus
20.CNRLEU Community Network of Reference Laboratories for human influenza
21.CNScentral nervous system
22.CNS-ICcentral nervous system infection — intracranial infection
23.CNS-MENcentral nervous system infection — meningitis or ventriculitis
24.CNS-SAcentral nervous system infection — spinal abscess without meningitis
25.C-PVCcatheter-related — peripheral venous catheter
26.CRIcatheter-related infection
27.CRSCongenital rubella syndrome
28.CRTcapillary refilling time
29.CSFCerebrospinal fluid
30.CT scancomputed tomography scan
31.CVScardiovascular system infection
32.CVS-CARDcardiovascular system infection — myocarditis or pericarditis
33.CVS-ENDOcardiovascular system infection — endocarditis
34.CVS-MEDcardiovascular system infection — mediastinitis
35.CVS-VASCcardiovascular system infection — arterial or venous infection
36.DFAdirect fluorescent antibody
37.DFA-TPdirect fluorescent antibody test for Treponema pallidum
38.DNAdeoxyribonucleic acid
39.DPAdistal protected aspirate
40.EARS-NetEuropean Antimicrobial Resistance Surveillance Network
41.ECDCEuropean Centre for Disease Prevention and Control
42.ECOFFsepidemiological cut-off values
43.EEGelectroencephalography
44.EENTeye, ear, nose, throat, or mouth infection
45.EENT-CONJeye, ear, nose, throat, or mouth infection — conjunctivitis
46.EENT-EAReye, ear, nose, throat, or mouth infection — ear mastoid
47.EENT-EYEeye, ear, nose, throat, or mouth infection — eye, other than conjunctivitis
48.EENT-ORALeye, ear, nose, throat, or mouth infection — oral cavity (mouth, tongue, or gums)
49.EENT-SINUeye, ear, nose, throat, or mouth infection — sinusitis
50.EENT-UReye, ear, nose, throat, or mouth infection — upper respiratory tract, pharyngitis, laryngitis, epiglottitis
51.EFNSEuropean Federation of Neurological Societies
52.EIAenzyme immunoassay
53.ELISAenzyme-linked immunosorbent assay
54.EMelectron microscopy
55.EUCASTEuropean Committee on Antimicrobial Susceptibility Testing
56.FAMAfluorescent antibody to membrane antigen
57.FTA-absfluorescent treponemal antibody absorption
58.FUOfever of unknown origin
59.GIgastrointestinal system infection
60.GI-CDIgastrointestinal system infection — Clostridium difficile infection
61.GI-GEgastrointestinal system infection — gastroenteritis (excl. CDI)
62.GI-GITgastrointestinal system infection — gastrointestinal tract (esophagus, stomach, small and large bowel, and rectum) excluding gastroenteritis and appendicitis
63.GI-HEPgastrointestinal system infection — hepatitis
64.GI-IABgastrointestinal system infection — intraabdominal, not specified elsewhere including gallbladder, bile ducts, liver (excluding viral hepatitis), spleen, pancreas, peritoneum, subphrenic or subdiaphragmatic space, or other intraabdominal tissue or area not specified elsewhere
65.HAIhealthcare-associated infections
66.HbeAghepatitis B e antigen
67.HbsAghepatitis B surface antigen
68.HBV-DNAhepatitis B nucleic acid
69.HCV-corehepatitis C virus core antigen
70.HCV-RNAhepatitis C virus nucleic acid
71.HIVhuman immunodeficiency virus
72.HUShaemolytic-uraemic syndrome
73.IAPintubation-associated pneumonia
74.IFAindirect fluorescent antibody
75.IgGimmunoglobulin G
76.IgMimmunoglobulin M
77.ILIinfluenza-like illness
78.LGVlymphogranuloma (venereum)
79.LPSlipopolysaccharides
80.LRIlower respiratory tract infection, other than pneumonia
81.LRI-BRONlower respiratory tract infection — bronchitis, tracheobronchitis, bronchiolitis, tracheitis, without evidence of pneumonia
82.TBETick-borne encephalitis
Any person with at least one of the following clinical forms:
Cutaneous anthrax
At least one the following two:
Papular or vesicular lesion;
Depressed black eschar with surrounding oedema.
Gastrointestinal anthrax
Fever or feverishness;
AND at least one of the following two:
Severe abdominal pain;
Diarrhoea.
Inhalational anthrax
Fever or feverishness;
AND at least one of the following two:
Acute respiratory distress;
Radiological evidence of mediastinal widening.
Meningeal/meningoencephalitic anthrax
Fever;
AND at least one of the following three:
Convulsions;
Loss of consciousness;
Meningeal signs.
Anthrax septicaemia
At least one of the following two:
Isolation of Bacillus anthracis from a clinical specimen
Detection of Bacillus anthracis nucleic acid in a clinical specimen
Positive nasal swab without clinical symptoms does not contribute to a confirmed diagnosis of a case.
At least one of the following three epidemiological links:
Animal to human transmission;
Exposure to a common source;
Exposure to contaminated food/drinking water.
A. Possible case NA
B. Probable case
Any person meeting the clinical criteria with an epidemiological link
C. Confirmed case
Any person meeting the clinical and the laboratory criteria
Note: If the national surveillance system is not capturing clinical symptoms, all laboratory-confirmed individuals should be reported as confirmed cases.
Any person with at least one of the following clinical forms:
Food-borne and wound botulism
At least one of the following two:
Bilateral cranial nerve impairment (for example, diplopia, blurred vision, dysphagia, bulbar weakness);
Peripheral symmetric paralysis.
Infant botulism
Any infant with at least one of the following six:
Constipation;
Lethargy;
Difficulty in sucking or feeding;
Ptosis;
Dysphagia;
General muscle weakness.
The type of botulism usually encountered in infants (< 12 months of age) can affect children also over 12 months of age and occasionally adults, with altered gastrointestinal anatomy and microflora
At least one of the following three:
Isolation of BoNT-producing clostridia (for example, Clostridium botulinum, C. baratii, C. butyricum) for infant botulism (stool) or wound botulism (wound);
Detection of botulinum neurotoxins in a clinical specimen;
Detection of genes encoding for botulinum neurotoxins in a clinical specimen.
At least one of the following two epidemiological links:
Exposure to a common source (for example, food, sharing of needles or other devices);
Exposure to contaminated food/drinking water
A. Possible case NA
B. Probable case
Any person meeting the clinical criteria with an epidemiological link
C. Confirmed case
Any person meeting the clinical and the laboratory criteria
Any person with fever
And at least one of the following seven:
Sweating (profuse, malodorous, specially nocturnal);
Chills;
Arthralgia;
Weakness;
Depression;
Headache;
Anorexia.
At least one of the following three:
Isolation of human pathogenic Brucella spp. from a clinical specimen;
Human pathogenic Brucella specific antibody response (Standard Agglutination Test, Complement Fixation, ELISA);
Detection of human pathogenic Brucella spp. nucleic acid in a clinical specimen.
At least one of the following five epidemiological links:
Exposure to contaminated food/drinking water;
Exposure to products from a contaminated animal (milk or milk products);
Animal to human transmission (contaminated secretions or organs for example, vaginal discharge, placenta);
Exposure to a common source;
Laboratory exposure.
A. Possible case NA
B. Probable case
Any person meeting the clinical criteria with an epidemiological link
C. Confirmed case
Any person meeting the clinical and the laboratory criteria
Note: If the national surveillance system is not capturing clinical symptoms, all laboratory-confirmed individuals should be reported as confirmed cases.
Any person with at least one of the following three:
Diarrhoea;
Abdominal pain;
Fever.
At least one of the following two:
Isolation of human pathogenic Campylobacter spp. from a clinical specimen;
Detection of Campylobacter spp. nucleic acid in a clinical specimen.
Note: Antimicrobial susceptibility testing of Campylobacter spp. should be performed on a representative subset of isolates
At least one of the following five epidemiological links:
Animal to human transmission;
Human to human transmission;
Exposure to a common source;
Exposure to contaminated food/drinking water;
Environmental exposure.
A. Possible case NA
B. Probable case
Any person meeting the clinical criteria with an epidemiological link
C. Confirmed case
Any person meeting the clinical and the laboratory criteria
Note: If the national surveillance system is not capturing clinical symptoms, all laboratory-confirmed individuals should be reported as confirmed cases.
The results of antimicrobial susceptibility tests must be reported according to the methods and criteria agreed between ECDC and Member States as specified in the EU protocol for harmonised monitoring of antimicrobial resistance in human Salmonella and Campylobacter isolates [The EU protocols, including future updates, can be found at the following ECDC webpage: https://ecdc.europa.eu/en/publications-data/eu-protocol-harmonised-monitoring-antimicrobial-resistance-human-salmonella-and-0].
Fever
Detection of chikungunya specific IgM antibodies in a single serum sample.
At least one of the following four:
Isolation of chikungunya virus from a clinical specimen;
Detection of chikungunya viral nucleic acid from a clinical specimen;
Detection of chikungunya specific IgM antibodies in a single serum sample AND confirmation by neutralisation;
Seroconversion or four-fold antibody titre increase of chikungunya specific antibodies in paired serum samples.
History of travel to, or residence in an area with documented on-going transmission of chikungunya, within the two-week period prior to the onset of symptoms
A. Possible case NA
B. Probable case
Any person meeting the clinical and the epidemiological criteria, and the laboratory criteria for a probable case
C. Confirmed case
Any person meeting the laboratory criteria for a confirmed case
Note: Serological results should be interpreted according to previous exposure to other flaviviral infections and the flavivirus vaccination status. Confirmed cases in such situations should be validated by serum neutralization assay or other equivalent assays.
Any person with at least one of the following clinical forms:
Chlamydial infection non-LGV
At least one of the following six:
Urethritis;
Epididymitis;
Acute salpingitis;
Acute endometritis;
Cervicitis;
Proctitis.
In newborn children at least one of the following two:
Conjunctivitis;
Pneumonia.
LGV
At least one of the following five:
Urethritis;
Genital ulcer;
Inguinal lymphadenopathy;
Cervicitis;
Proctitis.
At least one of the following three:
Isolation of Chlamydia trachomatis from a specimen of the ano-genital tract or from the conjunctiva;
Demonstration of Chlamydia trachomatis by DFA test in a clinical specimen;
Detection of Chlamydia trachomatis nucleic acid in a clinical specimen.
At least one of the following two:
Isolation of Chlamydia trachomatis from a specimen of the ano-genital tract or from the conjunctiva;
Detection of Chlamydia trachomatis nucleic acid in a clinical specimen.
AND
Identification of serovar (genovar) L1, L2 or L3
An epidemiological link by human to human transmission (sexual contact or vertical transmission)
A. Possible case NA
B. Probable case
Any person meeting the clinical criteria with an epidemiological link
C. Confirmed case
Any person meeting the laboratory criteria
Any person with at least one of the following two:
Diarrhoea;
Vomiting.
Isolation of Vibrio cholerae from a clinical specimen
AND
Demonstration of O1 or O139 antigen in the isolate
AND
Demonstration of cholera-enterotoxin or the cholera-enterotoxin gene in the isolate
At least one of the following four epidemiological links:
Exposure to a common source;
Human to human transmission;
Exposure to contaminated food/drinking water;
Environmental exposure.
A. Possible case NA
B. Probable case
Any person meeting the clinical criteria with an epidemiological link
C. Confirmed case
Any person meeting the clinical and the laboratory criteria;
Note: If the national surveillance system is not capturing clinical symptoms, all laboratory-confirmed individuals should be reported as confirmed cases.
Any person with a progressive neuropsychiatric disorder with a duration of illness of at least 6 months
Routine investigations do not suggest an alternative diagnosis
No history of exposure to human pituitary hormones or human dura mater graft
No evidence of a genetic form of transmissible spongiform encephalopathy
Any person with at least four of the following five:
Early psychiatric symptoms [Depression, anxiety, apathy, withdrawal, delusions];
Persistent painful sensory symptoms [This includes both frank pain and/or dysaesthesia];
Ataxia;
Myoclonus or chorea or dystonia;
Dementia.
Neuropathological confirmation: spongiform change and extensive prion protein deposition with florid plaques throughout the cerebrum and cerebellum
EEG does not show the typical appearance [The typical appearance of the EEG in sporadic CJD consists of generalised periodic complexes at approximately one per second. These may occasionally be seen in the late stages of vCJD] of sporadic CJD [The typical appearance of the EEG in sporadic CJD consists of generalised periodic complexes at approximately one per second. These may occasionally be seen in the late stages of vCJD] in the early stages of the illness;
Bilateral pulvinar high signal on MRI brain scan;
A positive tonsil biopsy [Tonsil biopsy is not recommended routinely nor in cases with EEG appearances typical of sporadic CJD, but may be useful in suspect cases in which the clinical features are compatible with vCJD and MRI does not show pulvinar high signal].
An epidemiological link by human to human transmission (for example, blood transfusion)
A. Possible case
Any person fulfilling the preconditions
AND
meeting the clinical criteria
AND
a negative EEG for sporadic CJD [The typical appearance of the EEG in sporadic CJD consists of generalised periodic complexes at approximately one per second. These may occasionally be seen in the late stages of vCJD]
B. Probable case
Any person fulfilling the preconditions
AND
meeting the clinical criteria
AND
a negative EEG for sporadic CJD [The typical appearance of the EEG in sporadic CJD consists of generalised periodic complexes at approximately one per second. These may occasionally be seen in the late stages of vCJD]
AND
a positive MRI brain scan
OR
Any person fulfilling the preconditions
AND
a positive tonsil biopsy
C. Confirmed case
Any person fulfilling the preconditions
AND
meeting the diagnostic criteria for case confirmation
Any person with at least one of the following two:
Diarrhoea;
Abdominal pain.
At least one of the following four:
Demonstration of Cryptosporidium oocysts in stool;
Demonstration of Cryptosporidium in intestinal fluid or small-bowel biopsy specimens;
Detection of Cryptosporidium nucleic acid in stool;
Detection of Cryptosporidium antigen in stool.
One of the following five epidemiological links:
Human to human transmission
Exposure to a common source
Animal to human transmission
Exposure to contaminated food/drinking water
Environmental exposure
A. Possible case NA
B. Probable case
Any person meeting the clinical criteria with an epidemiological link
C. Confirmed case
Any person meeting the clinical and the laboratory criteria
Note: If the national surveillance system is not capturing clinical symptoms, all laboratory-confirmed individuals should be reported as confirmed cases.
Fever
Detection of dengue specific IgM antibodies in a single serum sample
At least one of the following five:
Isolation of a dengue virus from a clinical specimen;
Detection of dengue viral nucleic acid from a clinical specimen;
Detection of dengue viral antigen from a clinical specimen;
Detection of dengue specific IgM antibodies in a single serum sample AND confirmation by neutralization;
Seroconversion or four-fold antibody titre increase of dengue specific antibodies in paired serum samples
History of travel to, or residence in an area with documented on-going transmission of dengue, within the two-week period prior to the onset of symptoms
A. Possible case NA
B. Probable case
Any person meeting the clinical and the epidemiological criteria, and the laboratory criteria for a probable case
C. Confirmed case
Any person meeting the laboratory criteria for a confirmed case.
Any person with at least one of the following clinical forms:
Classic Respiratory Diphtheria:
An upper respiratory tract illness with laryngitis or nasopharyngitis or tonsillitis
AND
an adherent membrane/pseudomembrane